Finance

Lists
000020:KRX
Dongwha Pharm Co Ltd
5 580,00 KRW
+1,09%
(+60,00) 1D
19 ოქტ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000020...
Open
5 470 KRW
High
5 580 KRW
Low
5 380 KRW
Mkt. cap
155,86 მლრ.
Avg. vol.
367,06 ათ.
Volume
217,64 ათ.
Dividend
1,16%
Quarterly dividend
16 KRW
Ex-dividend date
27 დეკ. 2024
P/E ratio
8,56
52-wk high
7 560 KRW
52-wk low
4 450 KRW
EPS
652 KRW
Shares outstanding
27,93 მლნ.
No. of employees
797
Open
5 470 KRW
High
5 580 KRW
Low
5 380 KRW
Mkt. cap
155,86 მლრ.
Avg. vol.
367,06 ათ.
Volume
217,64 ათ.
Dividend
1,16%
Quarterly dividend
16 KRW
Ex-dividend date
27 დეკ. 2024
P/E ratio
8,56
52-wk high
7 560 KRW
52-wk low
4 450 KRW
EPS
652 KRW
Shares outstanding
27,93 მლნ.
No. of employees
797
News stories
From web sources and news partners
About Dongwha Pharm Co Ltd
CEOიუ ჯუნ-ჰა | ჰან იონგ-ჰიუნ
Employees797
Founded25 სექ. 1897
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
122,00 მლრ.
123,70 მლრ.
130,61 მლრ.
136,93 მლრ.
Cost of goods sold
67,03 მლრდ.
71,57 მლრდ.
70,80 მლრდ.
77,61 მლრდ.
Cost of revenue
67,03 მლრდ.
71,57 მლრდ.
70,80 მლრდ.
77,61 მლრდ.
Research and development expenses
1,73 მლრდ.
20,32 მლრდ.
5,42 მლრდ.
6,51 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47,10 მლრდ.
33,31 მლრდ.
39,80 მლრდ.
39,78 მლრდ.
Operating expense
53,60 მლრდ.
56,63 მლრდ.
48,58 მლრდ.
49,03 მლრდ.
Total operating expenses
120,63 მლრ.
128,19 მლრ.
119,39 მლრ.
126,64 მლრ.
Operating income
1,37 მლრდ.
-4,50 მლრდ.
11,23 მლრდ.
10,29 მლრდ.
Other non operating income
641,83 მლნ.
-65,61 მლნ.
892,29 მლნ.
810,33 მლნ.
EBT including unusual items
875,23 მლნ.
-4,88 მლრდ.
8,07 მლრდ.
7,93 მლრდ.
EBT excluding unusual items
1,52 მლრდ.
-5,68 მლრდ.
10,74 მლრდ.
10,13 მლრდ.
Income tax expense
633,61 მლნ.
-3,15 მლრდ.
-1,58 მლრდ.
1,47 მლრდ.
Effective tax rate
72,39%
64,47%
-19,64%
18,49%
Other operating expenses
628,08 მლნ.
154,48 მლნ.
510,81 მლნ.
-342,78 მლნ.
Net income
957,13 მლნ.
454,02 მლნ.
10,02 მლრდ.
6,65 მლრდ.
Net profit margin
0,78%
0,37%
7,67%
4,85%
Earnings per share
-
-
-
-
Interest and investment income
1,10 მლრდ.
382,40 მლნ.
272,32 მლნ.
456,60 მლნ.
Interest expense
-1,30 მლრდ.
-1,47 მლრდ.
-1,42 მლრდ.
-1,45 მლრდ.
Net interest expenses
-206,66 მლნ.
-1,09 მლრდ.
-1,14 მლრდ.
-997,70 მლნ.
Depreciation and amortization charges
2,95 მლრდ.
1,09 მლრდ.
2,23 მლრდ.
2,29 მლრდ.
EBITDA
7,02 მლრდ.
1,28 მლრდ.
16,74 მლრდ.
15,87 მლრდ.
Gain or loss from assets sale
-2,36 მლნ.
11,97 მლნ.
-18,54 მლნ.
-63,85 მლნ.
AI content may include mistakes. Learn more
Google აპები